Immunodiagnosis of tuberculosis infection in children under the age of five - Which testing is feasible? Source: International Congress 2015 – Paediatric bronchology Year: 2015
Latent TB infection: Patient choices and completion of treatment Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Delay in pulmonary tuberculosis treatment in Croatia Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013
Do we need to screen for latent TB when initiating a methotrexate treatment? Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Knowledge and attitude about tuberculosis disease in a health workers population Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013
The risk of tuberculosis in HIV infected in the 12 years of observation Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Prevalence of latent tuberculosis infection among household contacts and community controls in South India Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Using results of new laboratory test for tuberculosis infection in children Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Factors associated with pulmonary tuberculosis treatment outcome in Kocaeli; Turkey Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Is it necessary to give tuberculosis treatment daily throughout? Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014
Home based tuberculosis (TB) care program Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Lymphocytopenia in pulmonary tuberculosis: Does it have a clinical value? Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
The causes of death among patients with tuberculosis Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
The particularities of new cases of tuberculosis at homeless people Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013
Silicosis, tuberculosis time bomb? Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
The feature of BCG complications in children Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013
Preventive treatment for latent tuberculosis infection Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment Source: International Congress 2015 – Latent TB infection and screening Year: 2015